![Kee-Hong Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kee-Hong Kim
Technik-/Wissenschafts-/F&E-Leiter bei
TENAYA THERAPEUTICS, INC.
Profil
Kee-Hong Kim is currently Chief Technology Officer at Tenaya Therapeutics, Inc. since 2018.
Former positions include Director-Process Development at Adverum Biotechnologies, Inc. from 2013 to 2015, Senior Vice President-Technical Operations at PTC Therapeutics GT, Inc. from 2017 to 2018, and Head-Gene Therapy Process at Shire, Inc. Education includes a doctorate from Colorado State University.
Aktive Positionen von Kee-Hong Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2018 |
Ehemalige bekannte Positionen von Kee-Hong Kim
| Unternehmen | Position | Ende |
|---|---|---|
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 |
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 01.04.2015 |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Corporate Officer/Principal | - |
Ausbildung von Kee-Hong Kim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Shire, Inc.
Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
